Atlas Trials

Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways)

Clinical trial NCT06221696 · COMPLETED

Trial details

NCT number
NCT06221696
Sponsor
S.LAB (SOLOWAYS)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Overweight and Obesity
Start date
2023-06-12
Primary completion
2023-11-23
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.